Related Experiment Video
Updated: May 6, 2026

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
Clinical Perspectives on Cochlear Implantation in Pediatric Patients with Cochlear Nerve Aplasia or Hypoplasia
Ava Raynor1, Sara Perez2, Megan Worthington2
1Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA 19104, USA.
Insights
Hearing professionals in the USA often prefer cochlear implantation (CI) for children with cochlear nerve deficiencies (CND). However, there
Area of Science:
- Otolaryngology
- Audiology
- Pediatric Medicine
Background:
- Cochlear implantation (CI) for pediatric cochlear nerve deficiencies (CND) is debated due to patient variability and inconsistent guidelines.
- Current practices for CI candidacy in children with CND in the USA are not well-defined.
Purpose of the Study:
- To evaluate US hearing healthcare professionals' perspectives on CI candidacy for children with CND.
- To understand current practices, including imaging and outcome expectations, for CI versus auditory brainstem implant (ABI) in pediatric CND cases.
Main Methods:
- An anonymous online survey with 19 questions was distributed to CI clinicians nationwide.
- Survey data included professional background, experience with cochlear aplasia/hypoplasia, and views on CI/ABI candidacy.
- Both multiple-choice and open-ended responses were analyzed.
Main Results:
- Most clinicians favored CI for hypoplasia (60.2%) and aplasia (41.7%), with audiologists more likely than neurotologists to support CI.
- Reasons for preferring CI over ABI included lower risk, accessibility, and potential benefit.
- A case-by-case approach, integrating imaging, electrophysiology, and counseling, was emphasized, but only 22.2% viewed structural factors as key predictors of success.
Conclusions:
- US hearing health professionals generally favor CI as a primary option for pediatric CND, despite diagnostic tool limitations.
- Significant variability exists in clinical perspectives on CI for pediatric aplasia and hypoplasia, indicating a lack of consensus.
- There is a need for standardized assessment and imaging protocols to improve consistency and develop evidence-based guidelines.
Abstract:
Background: Cochlear implantation (CI) in pediatric patients with cochlear nerve deficiencies (CND) remains controversial due to a highly variable clinical population, lack of evidence-based guidelines, and mixed research findings. This study assessed current clinical perspectives and practices regarding CI candidacy in children with CND among hearing healthcare professionals in the USA. Methods: An anonymous 19-question online survey was distributed to CI clinicians nationwide. The survey assessed professional background, experience with aplasia and hypoplasia, and perspectives on CI versus auditory brainstem implant (ABI) candidacy, including imaging practices and outcome expectations. Both multiple-choice and open-ended responses were analyzed to identify trends and reasoning. Results: Seventy-two responses were analyzed. Most clinicians supported CI for hypoplasia (60.2%) and, to a lesser extent, for aplasia (41.7%), with audiologists more likely than neurotologists to favor CI. Respondents cited lower risk, accessibility, and the potential for benefit as reasons to attempt CI before ABI. However, many emphasized a case-by-case approach, incorporating imaging, electrophysiological testing, and family counseling. Only 22.2% considered structural factors the best predictors of CI success. Conclusions: Overall, hearing health professionals in the USA tend to favor CI as a first-line option, while acknowledging the limitations of current diagnostic tools and the importance of individualized, multidisciplinary decision-making in CI candidacy for children with CND. Findings reveal a high variability in clinical perspectives on CI implantation for pediatric aplasia and hypoplasia and a lack of clinical consensus, highlighting the need for more standardized assessment and imaging protocols to provide greater consistency across centers and enable the development of evidence-based guidelines.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion

